Related Experiment Video
Updated: Apr 30, 2026

09:08
Integration of Bioinformatics Approaches and Experimental Validations to Understand the Role of Notch Signaling in Ovarian Cancer
Published on: January 12, 2020
6.3K
Identifying key genes, miRNAs, and pathways in keloid formation: A bioinformatics and experimental study
Jiao Kong1, Changcai Zhou2, Haiyan Qin1
1China-Japan Union Hospital of Jilin University, No. 126 of Xiantai Street, Changchun 130033, China.
Journal of Plastic, Reconstructive & Aesthetic Surgery : JPRAS
|February 14, 2025
Summary
Keloid formation involves key gene expression changes, particularly in extracellular matrix components. Targeting the miR-22-5p/RUNX2 pathway offers a promising new avenue for keloid treatment.
Area of Science:
- Dermatology
- Molecular Biology
- Bioinformatics
Background:
- Keloids are challenging skin growths with unpredictable behavior and limited treatment options.
- Understanding the molecular basis of keloid formation is crucial for developing effective therapies.
Purpose of the Study:
- To identify key gene expression alterations in keloid formation.
- To discover potential biomarkers and therapeutic targets for keloid disorders.
Main Methods:
- Analysis of gene expression in keloid and normal skin samples.
- Bioinformatic analysis of differentially expressed genes (DEGs) using Gene Ontology and KEGG pathways.
- Construction of a protein-protein interaction network.
- Identification of hub genes and differentially expressed microRNAs (miRNAs).
Main Results:
- Enriched pathways included collagen-containing extracellular matrix (ECM).
- Ten hub genes and one key microRNA, miR-22-5p, were identified.
- RUNX2 was validated as a crucial differentially expressed gene in keloid tissue.
- RUNX2, IGF1, EGF, and PPARGC1A were predicted targets of miR-22-5p.
Conclusions:
- The study elucidates molecular mechanisms underlying keloid formation.
- The miR-22-5p/RUNX2 axis presents a potential therapeutic target for keloid diagnosis and treatment.
- Findings provide a foundation for improved clinical management of keloid disorders.
Related Concept Videos
MicroRNAs
21.1K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
21.1K
mTOR Signaling and Cancer Progression
3.7K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.7K
MAPK Signaling Cascades
5.1K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
5.1K
PI3K/mTOR/AKT Signaling Pathway
3.4K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.4K

